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Is Microscopic Colitis Associated with Increased Risk for Other 
Gastrointestinal Diseases? 
Tanner Graves, Paul Koles MD 
Wright State University BSOM; Department of Pathology 
Introduction 
Microscopic colitis is clinically suspected in patients with
recurrent watery diarrhea and the absence of gross
pathologic changes in the colon by endoscopic examination.
The diagnosis is established only by microscopic evaluation
of colonic biopsies. Microscopic colitis is currently classified 
into three subgroups: collagenous colitis (CC), lymphocytic
colitis (LC), and combined CC and LC. The incidence rates
are 4.14 per 100,000 person-years and 4.85 per 100,000 
person-years for CC and LC, respectfully.
Diagnosis is typically made without measuring the exact
thickness of the subepithelial collagen band or by counting
the number of lymphocytes in the epithelium. There is little 
research done showing if these numbers are clinically
relevant. It may be important to know if these numbers relate 
to clinic progression or other important outcomes. 
Image 3: Current theory of pathophysiology of MC 
Known Associations 
• More common in females 
• Mean age of patients is 64.9 for CC and 62.2 for LC 
• Studies show increased rates of RA, IBD, celiac disease 
• Increased incidence in smokers 
• Positive association with NSAID and PPIs, and possibly
SSRI’s 
Gaps in Knowledge 
• Does severity of pathologic findings correlate with disease 
progression/severity or a risk of comorbid conditions? 
• Is there a strong association with MC and other
medications? 
• Does certain health parameters (BMI) correlate with






Image 2: Lymphocytic 
colitis can be determined 
by an increased number
of lymphocytes in the 
epithelium 
Methods 
• Collect 200 patient charts with microscopic colitis and sort
in lymphocytic colitis, collagenous colitis, and combined. 
• Examine slides and quantify number of lymphocytes in
epithelium and measure thickness of collagen band. 
• Patients will be split into severity category based on
disease markers 
• Collect patient demographics, medical data, and disease 
severity and duration 
Data Analysis 
• Relative risk of developing other GI/autoimmune diseases
based on severity of disease process 
• Chi-square testing of prevalence of various
GI/autoimmune diseases comparing patients with MC to 
general population 
• Linear regression between BMI and 
lymphocytes/thickness at time of diagnosis 
• Linear regression between disease duration and 
lymphocytes/thickness 
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